** Walter Reed Hospital & Department of Defense concluded that the FirstVue™ rapid test was the preferred test in all phases of this evaluation. The FirstVue™ HBSAG Test was Found to Have Higher Sensitivity and Specificity and ease of use than Other Rapid HBSAG Tests.

FirstVue™ HBsAg tests provide easy, fast and accurate diagnosis and can be relied upon almost anywhere in the world.

The simple two step tests require no power, no water, minimal training, just a fingerstick for sample collection and can be easily stored and transported.

Specimen Type : Whole Blood, Plasma or Serum
Screen For: Hepatitis B Virus Surface Antigen
Procedure: Easy One Step
Results: 5 Minutes
Storage: 18 months at Room Temperature
Internal Procedure Controls: Yes, positive and negative
Kit Sizes: 25, 50 tests
Availability: Subject to Order Confirmation

INTENDED USE: The FirstVue™ HBsAg Test cassette is a rapid immunochromatographic (micro lateral flow) assay designed for qualitative determination of hepatitis B surface antigen (HBsAg) in Whole Blood, Serum or Plasma.

PRINCIPLE: The FirstVue™ HBsAg Hepatitis B Surface Antigen Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative, solid phase, two-site sandwich immunoassay for the detection of HBsAg in whole blood, serum or plasma. The membrane is pre-coated with anti-HBsAg antibodies on the test line region of the Device. During testing, the whole blood, serum or plasma specimen reacts with the particle coated with anti-HBsAg antibodies. The mixture migrates upward on the membrane chromatographically by capillary action to react with anti-HBsAg antibodies on the membrane and generate a colored line. The presence of this colored line in the test region indicates a positive result, while its absence indicates a negative result. To serve as a procedural control, a colored line will always appear in the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.

“Hepatitis B is one of the major diseases of mankind and is a serious global public health problem” World Health Organization (WHO)